Catalyst Pharma Stock Price (NASDAQ:CPRX)

Add to My Stocks
$3.08 $0.13 (4.41%) CPRX stock closing price Jul 24, 2017 (Closing)
Prev Close* : $2.95
Market Cap:
Day Low: $2.92
52 Week Low: $0.68
Open: $2.98
Volume: 846828
Day High: $3.1
52 Week High: $3.16

Latest Stock Market News

Latest Articles

Catalyst Pharma News - From Partners

Catalyst Pharmaceuticals Joins Russell 3000 Index   by Globe Newswire on Jun 26, 2017

CPRX Stockcharts

View CPRX PE ratio, PS ratio stocks charts and compare with peers.
CPRX Chart
Note: Compare Catalyst Pharma stock price history with the index and industry peers.

CPRX Industry Peers

Company Price Change (%)
Dragon Jade International (DGJI)4.490 (0%)
Durect (DRRX)1.840.03 (1.6%)
Biomarin Pharma (BMRN)90.010.73 (0.82%)
Auspex Pharma (ASPX)100.960 (0%)
Acorda Therapeutics (ACOR)22.41.75 (8.47%)
Pfizer (PFE)33.320.16 (0.48%)
Abbott (ABT)50.80.04 (0.08%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
AcelRx Pharma (ACRX)3.650.5 (15.87%)
Genocea Biosciences (GNCA)5.830.78 (15.45%)
Concert Pharma (CNCE)16.12.07 (14.75%)
ImmunoGen (IMGN)6.340.68 (12.01%)
GlycoMimetics (GLYC)12.10.6 (5.22%)
Arrowhead Pharma (ARWR)1.580.07 (4.64%)
Catalyst Pharma (CPRX)3.080.13 (4.41%)
Top gainers from Medical-Drugs industry
* As of Jul 24, 2017
CompanyPriceChange (%)
Tetraphase Pharmaceuticals (TTPH)7.30.79 (9.77%)
Endo International (ENDP)11.670.71 (5.74%)
BioCryst Pharma (BCRX)5.20.21 (3.88%)
Corcept Therapeutics (CORT)12.530.44 (3.39%)
Lannett Co (LCI)210.5 (2.33%)
Durect (DRRX)1.840.03 (1.6%)
Grifols (GRFS)20.370.33 (1.59%)
Top losers from Medical-Drugs industry
* As of Jul 24, 2017

Catalyst Pharmaceuticals Inc Stock News - Partner Headlines

Catalyst Pharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues-----
Net Income-18.07M-20.23M-15.5M-12.15M-4.07M
Total Operating Expense19.27M20.39M14.58M10.3M5.21M
view Catalyst Pharmaceuticals Inc income statement
balance sheet20162015201420132012
Total Assets41.7M60.1M43.9M25.36M16.78M
Total Liabilities2.39M4.62M8.66M3.97M2.16M
Shareholders Equity39.3M55.47M35.24M21.39M14.62M
view Catalyst Pharmaceuticals Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-0.88M0.66M0.76M0.19M-0.28M
Net Cash From (Used By) Operating Activities-17.96M-18.01M-12.94M-9.87M-5.14M
Increase (Decrease) In Prop Plant And Equipment-0.09M-0.02M-0.05M-0.01M-0.05M
view Catalyst Pharmaceuticals Inc cashflow statement

Catalyst Pharma Stock Message Board

As of last trading day, Catalyst Pharma stock price was 2.95. Looking at Catalyst Pharma market capitalization, which currently stands at 257.89M, we can say that CPRX stock is a Micro cap stock. Catalyst Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Catalyst Pharma is worth a lot, it will most likely be reflected in an inflated Catalyst Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 889139 shares were traded with a closing stock price of 2.95 as of 21 Jul, 2017, as can be seen from Catalyst Pharma stock quote. One can view Catalyst Pharma stock chart to follow the stock price trend. To check the historical stock price movement, all time high, and all time low of CPRX, view Catalyst Pharma stock price history.